How to read these charts
Against the national standards
Each measure is drawn against its own NHS England standard: 95% for A&E within four hours, 85% for urgent cancer treatment within sixty-two days and 99% for diagnostic tests within six weeks. The charts do not share a standard and the three cancer measures are never added together.
Care Quality Commission
When CQC last rated this body
CQC has not rated Liverpool Women's NHS Foundation Trust since 23 June 2023. Its judgements from then are still on CQC’s own site and are not shown here, because a rating more than 3 years old is not what CQC currently says about a body.
Monthly performance against national standards
Hover or use the arrow keys to read any month, with the figures the percentage was worked out from. Every chart opens as a table.
A&E Wait Times
Patients seen within four hours
91.7%
August 2026: 91.7 per cent, 1,381 of 1,506 attendances. Below the 95% standard.
All 17 months as a table
| Month | Performance | Of attendances |
|---|---|---|
| Aug 2026 | 91.7%, Below the 95% standard | 1,381 of 1,506 |
| Jul 2026 | 91.7%, Below the 95% standard | 1,453 of 1,584 |
| Jun 2026 | 89.1%, Below the 95% standard | 1,303 of 1,462 |
| May 2026 | 91.0%, Below the 95% standard | 1,419 of 1,559 |
| Apr 2026 | 81.9%, Below the 95% standard | 1,223 of 1,493 |
| Mar 2026 | 87.3%, Below the 95% standard | 1,388 of 1,589 |
| Feb 2026 | 89.1%, Below the 95% standard | 1,271 of 1,427 |
| Jan 2026 | 89.6%, Below the 95% standard | 1,411 of 1,575 |
| Dec 2025 | 87.0%, Below the 95% standard | 1,202 of 1,382 |
| Nov 2025 | 80.7%, Below the 95% standard | 1,196 of 1,482 |
| Oct 2025 | 83.3%, Below the 95% standard | 1,334 of 1,601 |
| Sept 2025 | 93.5%, Below the 95% standard | 1,366 of 1,461 |
| Aug 2025 | 91.3%, Below the 95% standard | 1,275 of 1,396 |
| Jul 2025 | 88.6%, Below the 95% standard | 1,393 of 1,572 |
| Jun 2025 | 92.6%, Below the 95% standard | 1,358 of 1,467 |
| May 2025 | 86.5%, Below the 95% standard | 1,251 of 1,446 |
| Apr 2025 | 89.1%, Below the 95% standard | 1,367 of 1,535 |
Waiting times (RTT)
Referral to treatment: waiting under eighteen weeks to start treatment
63.9%
July 2026: 63.9 per cent, 7,442 of 11,643 people waiting. Below the 92% standard.
All 14 months as a table
| Month | Performance | Of people waiting |
|---|---|---|
| Jul 2026 | 63.9%, Below the 92% standard | 7,442 of 11,643 |
| Jun 2026 | 63.8%, Below the 92% standard | 7,468 of 11,700 |
| May 2026 | 63.0%, Below the 92% standard | 7,313 of 11,610 |
| Apr 2026 | 61.0%, Below the 92% standard | 7,211 of 11,826 |
| Mar 2026 | 60.1%, Below the 92% standard | 7,127 of 11,860 |
| Feb 2026 | 51.0%, Below the 92% standard | 6,815 of 13,372 |
| Jan 2026 | 49.1%, Below the 92% standard | 6,725 of 13,696 |
| Dec 2025 | 49.9%, Below the 92% standard | 7,178 of 14,378 |
| Nov 2025 | 49.0%, Below the 92% standard | 7,093 of 14,480 |
| Oct 2025 | 48.1%, Below the 92% standard | 7,518 of 15,629 |
| Sept 2025 | 46.9%, Below the 92% standard | 8,112 of 17,314 |
| Aug 2025 | 46.0%, Below the 92% standard | 7,738 of 16,831 |
| Jul 2025 | 46.4%, Below the 92% standard | 7,722 of 16,654 |
| Jun 2025 | 49.0%, Below the 92% standard | 8,095 of 16,537 |
Diagnostic tests (DM01)
Waiting under six weeks for a scan, a scope or a test
93.7%
July 2026: 93.7 per cent, 665 of 710 people waiting. Below the 99% standard.
All 4 months as a table
| Month | Performance | Of people waiting |
|---|---|---|
| Jul 2026 | 93.7%, Below the 99% standard | 665 of 710 |
| Jun 2026 | 95.8%, Below the 99% standard | 716 of 747 |
| May 2026 | 93.6%, Below the 99% standard | 661 of 706 |
| Apr 2026 | 91.8%, Below the 99% standard | 472 of 514 |
Cancer diagnosis (FDS)
Faster diagnosis standard: told the outcome within twenty-eight days
75.7%
July 2026: 75.7 per cent, 337 of 445 referrals. Meets the 75% standard.
All 7 months as a table
| Month | Performance | Of referrals |
|---|---|---|
| Jul 2026 | 75.7%, Meets the 75% standard | 337 of 445 |
| Jun 2026 | 73.0%, Below the 75% standard | 298 of 408 |
| May 2026 | 74.8%, Below the 75% standard | 258 of 345 |
| Apr 2026 | 79.0%, Meets the 75% standard | 259 of 328 |
| Mar 2026 | 75.4%, Meets the 75% standard | 304 of 403 |
| Feb 2026 | 72.0%, Below the 75% standard | 267 of 371 |
| Jan 2026 | 66.8%, Below the 75% standard | 233 of 349 |
Cancer (31-day)
Decision to treat to first treatment within thirty-one days
85.4%
July 2026: 85.4 per cent, 41 of 48 treatments. Below the 96% standard.
All 7 months as a table
| Month | Performance | Of treatments |
|---|---|---|
| Jul 2026 | 85.4%, Below the 96% standard | 41 of 48 |
| Jun 2026 | 86.4%, Below the 96% standard | 38 of 44 |
| May 2026 | 80.7%, Below the 96% standard | 25 of 31 |
| Apr 2026 | 85.7%, Below the 96% standard | 30 of 35 |
| Mar 2026 | 82.5%, Below the 96% standard | 33 of 40 |
| Feb 2026 | 89.2%, Below the 96% standard | 33 of 37 |
| Jan 2026 | 84.1%, Below the 96% standard | 37 of 44 |
Cancer (62-day)
Urgent referral to first treatment within sixty-two days
69.1%
July 2026: 69.1 per cent, 19 of 27.5 treatments. Below the 85% standard.
All 7 months as a table
| Month | Performance | Of treatments |
|---|---|---|
| Jul 2026 | 69.1%, Below the 85% standard | 19 of 27.5 |
| Jun 2026 | 71.4%, Below the 85% standard | 12.5 of 17.5 |
| May 2026 | 43.2%, Below the 85% standard | 8 of 18.5 |
| Apr 2026 | 55.8%, Below the 85% standard | 12 of 21.5 |
| Mar 2026 | 62.5%, Below the 85% standard | 12.5 of 20 |
| Feb 2026 | 63.8%, Below the 85% standard | 15 of 23.5 |
| Jan 2026 | 41.9%, Below the 85% standard | 13 of 31 |